Profile | GDS5420 / 237833_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 31.97 | 25 |
GSM1296119 | B_lesional_pre-dose | 80.84 | 36 |
GSM1296076 | C_lesional_pre-dose | 42.45 | 28 |
GSM1296092 | D_lesional_pre-dose | 54.46 | 34 |
GSM1296103 | E_lesional_pre-dose | 56.51 | 33 |
GSM1296078 | F_lesional_pre-dose | 36.98 | 26 |
GSM1296107 | G_lesional_pre-dose | 46.31 | 27 |
GSM1296109 | H_lesional_pre-dose | 73.06 | 35 |
GSM1296080 | I_lesional_pre-dose | 65.09 | 36 |
GSM1296090 | J_lesional_pre-dose | 41.38 | 29 |
GSM1296074 | K_lesional_pre-dose | 45.25 | 32 |
GSM1296111 | L_lesional_pre-dose | 94.48 | 38 |
GSM1296099 | M_lesional_pre-dose | 27.53 | 22 |
GSM1296086 | O_lesional_pre-dose | 44.11 | 30 |
GSM1296117 | P_lesional_pre-dose | 89.17 | 37 |
GSM1296113 | Q_lesional_pre-dose | 39.37 | 22 |
GSM1296096 | R_lesional_pre-dose | 4.4 | 5 |
GSM1296105 | S_lesional_pre-dose | 50.05 | 30 |
GSM1296098 | T_lesional_pre-dose | 51.5 | 29 |
GSM1296101 | U_lesional_pre-dose | 16.71 | 16 |
GSM1296121 | V_lesional_pre-dose | 80.5 | 37 |
GSM1296088 | W_lesional_pre-dose | 30.18 | 24 |
GSM1296082 | X_lesional_pre-dose | 38.98 | 29 |
GSM1296115 | Y_lesional_pre-dose | 57.19 | 31 |
GSM1296084 | Z_lesional_pre-dose | 59.68 | 33 |
GSM1296072 | B_lesional_day8 | 85.14 | 37 |
GSM1296069 | L_lesional_day8 | 107.39 | 39 |
GSM1296071 | P_lesional_day8 | 100.2 | 38 |
GSM1296070 | Y_lesional_day8 | 58.25 | 30 |
GSM1296073 | V_lesional_day8 | 51.21 | 30 |
GSM1296034 | A_lesional_day15 | 81.23 | 37 |
GSM1296041 | G_lesional_day15 | 55.86 | 30 |
GSM1296035 | R_lesional_day15 | 33.69 | 27 |
GSM1296038 | U_lesional_day15 | 23.39 | 21 |
GSM1296047 | B_lesional_day15 | 53.16 | 29 |
GSM1296039 | E_lesional_day15 | ||
GSM1296042 | H_lesional_day15 | 60.06 | 31 |
GSM1296043 | L_lesional_day15 | 96.37 | 38 |
GSM1296037 | M_lesional_day15 | 69.69 | 35 |
GSM1296046 | P_lesional_day15 | 92.81 | 37 |
GSM1296044 | Q_lesional_day15 | 47.06 | 27 |
GSM1296045 | Y_lesional_day15 | 65.65 | 31 |
GSM1296025 | C_lesional_day15 | 114.9 | 44 |
GSM1296033 | D_lesional_day15 | 56.74 | 33 |
GSM1296027 | I_lesional_day15 | 56.15 | 35 |
GSM1296032 | J_lesional_day15 | 43.29 | 29 |
GSM1296024 | K_lesional_day15 | 86.05 | 40 |
GSM1296031 | W_lesional_day15 | 91.27 | 39 |
GSM1296028 | X_lesional_day15 | 64.85 | 35 |
GSM1296029 | Z_lesional_day15 | 71.12 | 37 |
GSM1296026 | F_lesional_day15 | 56.99 | 33 |
GSM1296030 | O_lesional_day15 | 44.85 | 32 |
GSM1296040 | S_lesional_day15 | 19.89 | 17 |
GSM1296036 | T_lesional_day15 | 34.47 | 24 |
GSM1296048 | V_lesional_day15 | 85.76 | 38 |
GSM1296059 | A_lesional_day43 | 58.53 | 34 |
GSM1296066 | G_lesional_day43 | 84.34 | 36 |
GSM1296060 | R_lesional_day43 | 61.53 | 34 |
GSM1296063 | U_lesional_day43 | 54.1 | 32 |
GSM1296064 | E_lesional_day43 | 36.3 | 26 |
GSM1296067 | H_lesional_day43 | 71.16 | 33 |
GSM1296062 | M_lesional_day43 | 44.61 | 30 |
GSM1296068 | Q_lesional_day43 | 60.75 | 29 |
GSM1296050 | C_lesional_day43 | 90.35 | 40 |
GSM1296057 | D_lesional_day43 | 64.46 | 35 |
GSM1296052 | I_lesional_day43 | 60.48 | 36 |
GSM1296054 | J_lesional_day43 | 80.71 | 37 |
GSM1296049 | K_lesional_day43 | 34.66 | 25 |
GSM1296055 | W_lesional_day43 | 53.42 | 31 |
GSM1296053 | X_lesional_day43 | 76.33 | 37 |
GSM1296058 | Z_lesional_day43 | 53.17 | 33 |
GSM1296051 | F_lesional_day43 | 81.78 | 39 |
GSM1296056 | O_lesional_day43 | 74.32 | 38 |
GSM1296065 | S_lesional_day43 | 17.74 | 17 |
GSM1296061 | T_lesional_day43 | 51.27 | 30 |
GSM1296095 | A_non-lesional_pre-dose | 21.17 | 19 |
GSM1296120 | B_non-lesional_pre-dose | 75.61 | 35 |
GSM1296077 | C_non-lesional_pre-dose | 52.27 | 32 |
GSM1296093 | D_non-lesional_pre-dose | 97.27 | 40 |
GSM1296104 | E_non-lesional_pre-dose | 42.89 | 28 |
GSM1296079 | F_non-lesional_pre-dose | 58.25 | 33 |
GSM1296108 | G_non-lesional_pre-dose | 44.51 | 27 |
GSM1296110 | H_non-lesional_pre-dose | 46.33 | 26 |
GSM1296081 | I_non-lesional_pre-dose | 55.64 | 35 |
GSM1296091 | J_non-lesional_pre-dose | 46.94 | 31 |
GSM1296075 | K_non-lesional_pre-dose | 73.13 | 37 |
GSM1296112 | L_non-lesional_pre-dose | 117.96 | 40 |
GSM1296100 | M_non-lesional_pre-dose | 34.17 | 25 |
GSM1296087 | O_non-lesional_pre-dose | 57.65 | 35 |
GSM1296118 | P_non-lesional_pre-dose | 105.25 | 39 |
GSM1296114 | Q_non-lesional_pre-dose | 66.93 | 32 |
GSM1296097 | R_non-lesional_pre-dose | 27.41 | 23 |
GSM1296106 | S_non-lesional_pre-dose | 16.69 | 15 |
GSM1296102 | U_non-lesional_pre-dose | 37.84 | 26 |
GSM1296122 | V_non-lesional_pre-dose | 101.74 | 40 |
GSM1296089 | W_non-lesional_pre-dose | 37.15 | 25 |
GSM1296083 | X_non-lesional_pre-dose | 55.35 | 33 |
GSM1296116 | Y_non-lesional_pre-dose | 92.7 | 37 |
GSM1296085 | Z_non-lesional_pre-dose | 59.84 | 34 |